Prognostic Stage IIA Breast Cancer AJCC v8 Recruiting Phase 2 Trials for Sargramostim (DB00020)

Also known as: Prognostic Stage 2A Breast Cancer AJCC v8

IndicationStatusPhase
DBCOND0109633 (Prognostic Stage IIA Breast Cancer AJCC v8)Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT05455658STEMVAC in Patients With Early Stage Triple Negative Breast CancerPrevention